Rhodes Jennifer J

EVP, Chief Legal Officer, Sec | See Remarks

2 companies

Insider Signal Score

Excellent

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

+38.8%

Avg 12M Return

+86.5%

Rhodes Jennifer J is a See Remarks at Elicio Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $559K based on current market prices.

Holdings by Company

ELTXDec 14, 2021

Current Shares30.4K

Value$304.3K

Net Activity-5,274

Bought: 0Sold: 5.3K

ACADMar 25, 2026

Current Shares11.3K

Value$254.5K

Net Activity-3,844

Bought: 0Sold: 3.8K

Transaction History

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 25, 2026	ACAD Acadia Pharmaceuticals Inc.	EVP, Chief Legal Officer, Sec	Sale+OE	3,844	$21.47	$82,530.68	-25.4%	-	-
Dec 14, 2021	ELTX Elicio Therapeutics, Inc.	See Remarks	Sell	451	$2.42	$1,090.11	-1.5%	-26.8%	-65.5%
Nov 15, 2021	ELTX Elicio Therapeutics, Inc.	See Remarks	Sell	433	$4.40	$1,905.20	-1.4%	-49.2%	-79.8%
Oct 14, 2021	ELTX Elicio Therapeutics, Inc.	See Remarks	Sell	430	$8.65	$3,719.50	-1.4%	-68.3%	-88.2%
Sep 14, 2021	ELTX Elicio Therapeutics, Inc.	See Remarks	Sell	430	$10.64	$4,575.20	-1.3%	-76.4%	-88.9%
Aug 16, 2021	ELTX Elicio Therapeutics, Inc.	See Remarks	Sell	445	$10.68	$4,752.60	-1.4%	-59.2%	-90.0%
Jul 21, 2021	ELTX Elicio Therapeutics, Inc.	See Remarks	Sell	432	$10.94	$4,726.08	-1.3%	-25.2%	-90.8%
Jul 14, 2021	ELTX Elicio Therapeutics, Inc.	See Remarks	Sell	431	$11.01	$4,745.31	-1.3%	-16.9%	-89.9%
Jun 14, 2021	ELTX Elicio Therapeutics, Inc.	See Remarks	Sell	427	$13.27	$5,666.29	-1.3%	-17.7%	-87.9%
May 14, 2021	ELTX Elicio Therapeutics, Inc.	See Remarks	Sell	440	$13.92	$6,124.80	-1.3%	-22.9%	-90.8%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC